September 10, 2019
August 20, 2019 | Inside Health Policy
An article published by Inside Health Policy quoted Aaron Josephson, Senior Director at ML Strategies, extensively in response to recent debate surrounding the U.S. Food and Drug Administration’s proposed rule “Reporting Information Regarding Falsification of Data,” which was previously withdrawn.
August 14, 2019 | WBUR
On August 12, Senior Vice President of ML Strategies Stephen Silveira was a guest on WBUR, Boston’s NPR News Station to discuss the Massachusetts Department of Transportation’s recent report on traffic congestion, as well as the Massachusetts Bay Transportation Authority’s plans to shut down key sections of the Red, Orange and Green Lines during weekends in the fall.
August 14, 2019 | Boston Globe
The Boston Globe reported that the administration of Governor Charlie Baker has responded to data released by the Massachusetts Department of Transportation confirming that traffic congestion in the state has reached a “tipping point.” In the August 9 article, Senior Vice President of ML Strategies Stephen Silveira said that he supported the Baker administration’s prospective solution of opt-in toll lanes to ease traffic.
July 30, 2019 | The Lobbying Show
David O’Connor, Senior Vice President for Energy & Clean Technology at ML Strategies, was recently featured as a guest on an episode of The Lobbying Show, a podcast about the world of lobbying: how it works, who is lobbying, and how to be effective.
July 25, 2019 | Inside Health Policy
Acting U.S. Food and Drug Administration Commissioner Ned Sharpless told agency staff in an email on July 23 that his top priorities are to develop frameworks for regulating new technologies; invest in the agency's workforce; help to lower drug prices by encouraging drug competition; and improve postmarket surveillance of regulated products. In an article published by Inside Health Policy, ML Strategies Senior Director Aaron Josephson commented extensively on Sharpless’ priority list.